Price target upside
Royalty Pharma plc - Class A Ordinary Shares Price Target Upside or Downside
RPRX price target upside based on the current price and analyst average.
Direct answer
Royalty Pharma plc - Class A Ordinary Shares's analyst target implies +10.9%.
The average target is $63.75 compared with a recorded current price of $57.51.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 10, 2026.
Get free Royalty Pharma plc - Class A Ordinary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $57.51
- Average price target
- $63.75
- High price target
- $70.00
- Low price target
- $58.00
- Target upside
- +10.9%
- Consensus rating
- Buy
- Analysts
- 8
- Evidence date
- August 10, 2026
- Valid through
- August 17, 2026